Dibucaine Hydrochloride from Japan
Dibucaine hydrochloride, also known as cinchocaine, serves as a potent local anesthetic for topical dermatological applications like sunburn relief. It qualifies for HTS 2922.50.1700 as an aromatic amino-compound featuring oxygen functions, explicitly listed among local anesthetics. Typically imported in crystalline powder form for pharmaceutical compounding.
Duty Rate — Japan → United States
21%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Submit EPA TSCA certification if any impurities exceed trace levels, per chemical import regulations
• Label shipments clearly as 'pharmaceutical intermediate - not for direct consumer use' to maintain Chapter 29 status
• Conduct stability testing documentation to qualify stabilizers under Chapter Note (f) without reclassification